Cargando…

Combination of Advanced Lung Cancer Inflammation Index and C-Reactive Protein Is a Prognostic Factor in Patients With Operable Non-Small Cell Lung Cancer

BACKGROUND: Previous study of ours showed that advanced lung cancer inflammation index (ALI) and C-reactive protein (CRP) are independent significant prognostic factors in operable non-small cell lung cancer (NSCLC) patients. Since both ALI and CRP are markers of inflammation, the aim of this study...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tomita, Masaki, Ayabe, Takanori, Maeda, Ryo, Nakamura, Kunihide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5755624/ https://www.ncbi.nlm.nih.gov/pubmed/29317962 http://dx.doi.org/10.14740/wjon1076w

Ejemplares similares

The Inflammatory Prognostic Index Predicts Cancer-Specific Outcomes of Patients with Resected Non-Small Cell Lung Cancer
por: Tomita, Masaki, et al.
Publicado: (2018)

Comparison of Inflammation-Based Prognostic Scores in Patients undergoing Curative Resection for Non-small Cell Lung Cancer
por: Tomita, Masaki, et al.
Publicado: (2018)

The Prognostic Values of a Novel Preoperative Inflammation-Based Score in Japanese Patients With Non-Small Cell Lung Cancer
por: Tomita, Masaki, et al.
Publicado: (2019)

Serum Carcinoembryonic Antigen Level Predicts Cancer-Specific Outcomes of Resected Non-Small Cell Lung Cancer With Interstitial Pneumonia
por: Tomita, Masaki, et al.
Publicado: (2018)

Low Body Mass Index Is an Independent Predictive Factor after Surgical Resection in Patients with Non-Small Cell Lung Cancer
por: Tomita, Masaki, et al.
Publicado: (2017)

Intrathoracic scapular dislocation following lung cancer resection
por: Tomita, Masaki, et al.
Publicado: (2018)

Does Obesity-Related Hemodilution of Carcinoembryonic Antigen Exist in Non-Small Cell Lung Cancer Patients?
por: Tomita, Masaki, et al.
Publicado: (2017)

Prognostic Significance of a Tumor Marker Index Based on Preoperative Serum Carcinoembryonic Antigen and Krebs von den Lungen-6 Levels in Non-Small Cell Lung Cancer
por: Tomita, Masaki, et al.
Publicado: (2017)

Isolated Renal Metastasis from Non-Small-Cell Lung Cancer: Report of 2 Cases
por: Tomita, Masaki, et al.
Publicado: (2015)

Preoperative Total Serum Cholesterol and Patients' Survival in Resected Nonsmall Cell Lung Cancer
por: Tomita, Masaki, et al.
Publicado: (2012)

Emergent Completion Pneumonectomy for Postoperative Hemorrhage from Rupture of the Infected Pulmonary Artery in Lung Cancer Surgery
por: Ayabe, Takanori, et al.
Publicado: (2011)

Resected thymic large cell neuroendocrine carcinoma: A case report and review of the literature
por: Ogata, Shogo, et al.
Publicado: (2019)

A case of spontaneous hemopneumothorax in which the condition worsened after chest drainage
por: Nose, Naohiro, et al.
Publicado: (2018)

Port-site implantation of Type A Masaoka Stage I thymoma after video-assisted thoracic surgery: a case report
por: Nose, Naohiro, et al.
Publicado: (2016)

Thymoma (World Health Organization type B3) with neuroendocrine differentiation in multiple endocrine neoplasia type 1
por: Tomita, Masaki, et al.
Publicado: (2017)

Advanced Lung Cancer Inflammation Index is a Prognostic Factor of Patients with Small-Cell Lung Cancer Following Surgical Resection
por: Hu, Zhonghui, et al.
Publicado: (2021)

Primary mucinous adenocarcinoma of the thymus: A case report
por: Hamahiro, Tomoka, et al.
Publicado: (2021)

Pulmonary torsion after resuscitative thoracotomy: a case report
por: Hara, Daisuke, et al.
Publicado: (2021)

Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI
por: Kim, Eun Young, et al.
Publicado: (2016)

Prognostic Value of the Advanced Lung Cancer Inflammation Index in Patients with Lung Cancer: A Meta-Analysis
por: Zhang, Yi, et al.
Publicado: (2019)

Systemic immune-inflammation index is a stage-dependent prognostic factor in patients with operable non-small cell lung cancer
por: Fu, Fangqiu, et al.
Publicado: (2021)

Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer
por: Pinato, D J, et al.
Publicado: (2014)

Prognostic Impact of the Advanced Lung Cancer Inflammation Index (ALI) in Metastatic Non-Small Cell Lung Cancer Treated with First Line Chemotherapy
por: Chantharakhit, Chaichana, et al.
Publicado: (2021)

The prognostic significance of the advanced lung cancer inflammation index in patients with unresectable metastatic colorectal cancer: a retrospective study
por: Shibutani, Masatsune, et al.
Publicado: (2019)

The prognostic value of the advanced lung cancer inflammation index (ALI) for patients with neuroblastoma
por: Qi, Can, et al.
Publicado: (2022)

The prognostic value of the advanced lung cancer inflammation index in patients with gastrointestinal malignancy
por: Zhang, Lilong, et al.
Publicado: (2023)

Intrapulmonary solitary fibrous tumor coexisting with lung adenocarcinomas
por: Kuroki, Shoei, et al.
Publicado: (2022)

Recurrent solitary fibrous tumor of the pleura with malignant transformation: a case report
por: Sakamoto, Risa, et al.
Publicado: (2021)

Lung immune prognostic index as a prognostic factor in patients with small cell lung cancer
por: Sonehara, Kei, et al.
Publicado: (2020)

Prognostic ability of lung immune prognostic index in limited-stage small cell lung cancer
por: Sun, Bochen, et al.
Publicado: (2022)

Prognostic role of the advanced lung cancer inflammation index in cancer patients: a meta-analysis
por: Hua, Xin, et al.
Publicado: (2019)

Exploring the implications of modified advanced lung cancer inflammation index on outcomes in patients with advanced non-small cell lung cancer
por: Mahajan, Abhishek, et al.
Publicado: (2023)

Use of the Advanced Lung Cancer Inflammation Index as a Prognostic Indicator for Patients With Cholangiocarcinoma
por: Wu, Huasheng, et al.
Publicado: (2022)

Systemic Inflammation and Lung Cancer: Is It a Real Paradigm? Prognostic Value of Inflammatory Indexes in Patients with Resected Non-Small-Cell Lung Cancer
por: Mazzella, Antonio, et al.
Publicado: (2023)

The Lung Immune Prognostic Index (LIPI) stratifies prognostic groups in advanced non-small cell lung cancer (NSCLC) patients
por: Aldea, Mihaela, et al.
Publicado: (2020)

Systemic immune-inflammation index and prognosis of advanced non-small cell lung cancer
por: Alifano, Marco
Publicado: (2020)

Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review
por: Jafri, Syed H, et al.
Publicado: (2013)

External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients
por: Barth, Dominik Andreas, et al.
Publicado: (2020)

Radiological features and surgical management of lung abscess directly extending into the chest wall: A case report
por: Kuroki, Shoei, et al.
Publicado: (2023)

The prognostic value of advanced lung cancer inflammation index (ALI) in elderly patients with heart failure
por: Yuan, Xiao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_psbt9fjg09j494136erv40cbhc